Respiratory Support & Defense

A clearly disclosed sustained-release PABA formula provides a much more substantial amount than the original. It is less comprehensive and offers no N-acetyl-L-cysteine or respiratory botanical support.

A named Testofen extract identified by fenusides gives the fenugreek component better definition than the original plain powder. The formula omits PABA and all respiratory-focused ingredients, so its advantage is limited to fenugreek quality.

A named Libifem fenugreek extract provides a more substantial and better-defined fenugreek component than the original plain powder. Added theanine, lemon balm, and vitamin D shift the purpose away from respiratory support, while PABA and N-acetyl-L-cysteine are absent.

The lower-cost serving doubles the original PABA amount in a short, fully disclosed formula. It does not replace N-acetyl-L-cysteine or the respiratory botanicals, so it is useful only when PABA is the main priority.

The economical single-ingredient formula provides substantially more PABA than the original blend. Its narrow design gives up N-acetyl-L-cysteine, fenugreek, and every respiratory herb in the original.

A lower-cost serving supplies much more fenugreek than the lightly dosed powder in the original. No PABA, N-acetyl-L-cysteine, or respiratory herbs are included, making it a focused fenugreek option rather than a direct substitute.

The simple formula provides twice the original PABA amount with strong serving value and full dose disclosure. It remains a narrow choice because the original respiratory ingredients and fenugreek are absent.

A low serving cost and a clearly stated PABA amount make this a practical way to emphasize one of the original collections. The trade-off is the loss of N-acetyl-L-cysteine, fenugreek, and the full respiratory herb blend.

The economical serving delivers far more fenugreek than the original formula. It offers good value for a fenugreek-only goal but does not match the original respiratory focus or PABA content.